Connect with us

Hi, what are you looking for?

Jewish Business News


US Supreme Court agrees to hear Teva Copaxone appeal


The US Supreme Court has agreed to hear an appeal by Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) over the expiry of its patents for Copaxone, its treatment for multiple sclerosis. The hearing could delay the expiration of the drug’s US patents until September 2015. They patents are due to expire in May.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at
Thank you.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.